Search
Xeruborbactam
go.drugbank.com/drugs/DB21512InvestigationalXeruborbactam is a small molecule drug. The usage of the INN stem '-bactam' in the name indicates that Xeruborbactam is a ẞ-lactamase inhibitor. … Xeruborbactam is under investigation in clinical trial NCT07104162 (A Study to Investigate Safety and Pharmacokinetics of Intravenous Cefiderocol/Xeruborbactam in Participants With Renal Impairment).
Gridegalutamide
go.drugbank.com/drugs/DB21593InvestigationalGridegalutamide is a small molecule drug. The usage of the INN stem '-lutamide' in the name indicates that Gridegalutamide is a non-steroid antiandrogen. … Gridegalutamide has a monoisotopic molecular weight of 818.32 Da.
Docirbrutinib
go.drugbank.com/drugs/DB21606InvestigationalDocirbrutinib is a small molecule drug. The usage of the INN stem '-brutinib' in the name indicates that Docirbrutinib is a agammaglobulinaemia tyrosine kinase (Bruton tyrosine kinase) inhibitor. … Docirbrutinib has a monoisotopic molecular weight of 578.24 Da.
Lomedeucitinib
go.drugbank.com/drugs/DB21649InvestigationalLomedeucitinib is a small molecule drug. The usage of the INN stem '-citinib' in the name indicates that Lomedeucitinib is a Janus kinase inhibitor. … Lomedeucitinib is under investigation in clinical trial NCT05730725 (A Study to Evaluate Effectiveness and Safety of BMS-986322 in Participants With Moderate-to-Severe Psoriasis).
Bimokalner
go.drugbank.com/drugs/DB21717InvestigationalBimokalner is a small molecule drug. The usage of the INN stem '-kalner' in the name indicates that Bimokalner is a opener of calcium-activated (maxi-K) K+-channel. … Bimokalner has a monoisotopic molecular weight of 355.1 Da.
Roxarsone
go.drugbank.com/drugs/DB11458ExperimentalVet approvedThe drug is also approved in the United States for use in pigs. … Roxarsone is an organoarsenic molecule added to poultry feed.
International brands: Ren-O-SalFluciclatide
go.drugbank.com/drugs/DB14842InvestigationalFluciclatide, an investigational radiotracer intended for PET imaging, was under investigation in clinical trials NCT00565721 and NCT01961583 to evaluate its ability to detect tumors and angiogenesis. … The conditions targeted by [18F]Fluciclatide in these studies include high-grade glioma, lung cancer, and kidney neoplasms
AEM-28-14
go.drugbank.com/drugs/DB17643ExperimentalAEM-28-14 is an analog of [AEM-28], an apolipoprotein E mimetic peptide, with a 400 percent greater cholesterol-lowering efficacy and a several-fold increase in drug tolerability.
D-Glutamine
go.drugbank.com/drugs/DB02174ExperimentalA non-essential amino acid present abundantly throughout the body and is involved in many metabolic processes. It is synthesized from glutamic acid and ammonia. … It is the principal carrier of nitrogen in the body and is an important energy source for many cells.